Earnings Call · Q3 FY2024·2024-11-07

Q3 24EPS +60.00%·Rev n/aQ2 24EPS -5.26%·Rev n/aQ1 24EPS -12.50%·Rev n/aQ4 23EPS -65.79%·Rev n/a⚠ consensus missing

Skye Bioscience, Inc. SKYE

Bernie Hertel — Unknown

Punit Dhillon — Chief Executive Officer

Kaitlyn Arsenault — Chief Financial Officer

+5.0%1d on move date+4.5% vs SPY3d−0.9%5d+1.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SKYE calls or request research access.

More SKYE calls Browse calls Request research access